Snowden Capital Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $613K | Buy |
7,196
+1,115
| +18% | +$99.4K | 0.02% | 708 |
|
|
2025
Q4 | $481K | Buy |
6,081
+404
| +7% | +$31.7K | 0.01% | 824 |
|
|
2025
Q3 | $454K | Sell |
5,677
-1,215
| -18% | -$104K | 0.01% | 833 |
|
|
2025
Q2 | $626K | Buy |
6,892
+643
| +10% | +$58.7K | 0.02% | 675 |
|
|
2025
Q1 | $586K | Sell |
6,249
-899
| -13% | -$80.5K | 0.02% | 677 |
|
|
2024
Q4 | $650K | Sell |
7,148
-860
| -11% | -$82.1K | 0.02% | 660 |
|
|
2024
Q3 | $831K | Sell |
8,008
-412
| -5% | -$42K | 0.02% | 571 |
|
|
2024
Q2 | $817K | Buy |
8,420
+535
| +7% | +$49.4K | 0.02% | 569 |
|
|
2024
Q1 | $710K | Buy |
7,885
+2,058
| +35% | +$174K | 0.02% | 617 |
|
|
2023
Q4 | $464K | Buy |
5,827
+373
| +7% | +$28K | 0.02% | 731 |
|
|
2023
Q3 | $388K | Sell |
5,454
-2,656
| -33% | -$199K | 0.02% | 761 |
|
|
2023
Q2 | $625K | Buy |
8,110
+893
| +12% | +$69.1K | 0.02% | 628 |
|
|
2023
Q1 | $542K | Sell |
7,217
-427
| -6% | -$31.8K | 0.02% | 698 |
|
|
2022
Q4 | $602K | Buy |
7,644
+124
| +2% | +$9.3K | 0.03% | 629 |
|
|
2022
Q3 | $528K | Sell |
7,520
-887
| -11% | -$69.5K | 0.02% | 630 |
|
|
2022
Q2 | $673K | Buy |
8,407
+1,740
| +26% | +$136K | 0.03% | 524 |
|
|
2022
Q1 | $505K | Buy |
6,667
+3,541
| +113% | +$280K | 0.02% | 628 |
|
|
2021
Q4 | $266K | Sell |
3,126
-6,492
| -67% | -$507K | 0.01% | 601 |
|
|
2021
Q3 | $727K | Sell |
9,618
-773
| -7% | -$61.4K | 0.04% | 442 |
|
|
2021
Q2 | $845K | Buy |
10,391
+1,446
| +16% | +$118K | 0.04% | 415 |
|
|
2021
Q1 | $705K | Buy |
8,945
+617
| +7% | +$48.4K | 0.04% | 414 |
|
|
2020
Q4 | $712K | Buy |
8,328
+2,838
| +52% | +$235K | 0.05% | 365 |
|
|
2020
Q3 | $424K | Buy |
5,490
+542
| +11% | +$41.3K | 0.03% | 419 |
|
|
2020
Q2 | $362K | Buy |
4,948
+614
| +14% | +$43.6K | 0.03% | 438 |
|
|
2020
Q1 | $288K | Sell |
4,334
-36
| -0.8% | -$2.54K | 0.03% | 442 |
|
|
2019
Q4 | $301K | Buy |
4,370
+34
| +0.8% | +$2.32K | 0.03% | 484 |
|
|
2019
Q3 | $319K | Sell |
4,336
-185
| -4% | -$13.4K | 0.03% | 415 |
|
|
2019
Q2 | $324K | Buy |
4,521
+11
| +0.2% | +$781 | 0.03% | 401 |
|
|
2019
Q1 | $309K | Buy |
+4,510
| New | +$291K | 0.03% | 401 |
|
|
2018
Q4 | – | Sell |
-3,087
| Closed | -$207K | – | 470 |
|
|
2018
Q3 | $207K | Buy |
+3,087
| New | +$206K | 0.02% | 472 |
|
|
2018
Q2 | – | Sell |
-3,884
| Closed | -$278K | – | 437 |
|
|
2018
Q1 | $278K | Buy |
+3,884
| New | +$280K | 0.04% | 332 |
|
Other funds holding CL
VCM
DAM
VPM
Snowden Capital Advisors's CL Position: Q1 2026 in Review
Snowden Capital Advisors increased its Colgate-Palmolive (CL) stake by 18% in Q1 2026, buying an estimated $99.4K and bringing the position to 7,196 shares worth $613K. The position accounts for 0.02% of the portfolio, ranked #708.
Snowden Capital Advisors first reported a position in CL in Q1 2018 and has held it in 31 quarters since. The position peaked at $845K in Q2 2021. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Snowden Capital Advisors held 7,196 shares of Colgate-Palmolive worth $613K as of Q1 2026.
- Snowden Capital Advisors bought 1,115 Colgate-Palmolive shares in Q1 2026, an estimated $99.4K.
- Colgate-Palmolive made up 0.02% of Snowden Capital Advisors's portfolio in Q1 2026, its #708 holding.
- Snowden Capital Advisors first reported a position in Colgate-Palmolive in Q1 2018 and has held it in 31 quarters since.
- Snowden Capital Advisors's Colgate-Palmolive position peaked at $845K in Q2 2021.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.